EQUALAN PHARMA EUROPE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
EQUALAN PHARMA EUROPE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
Contacts
Registered address
Copy
Website
-
Not calculatedReliability
Prescore cannot be calculated because the company delayed submission of financial statements.
Incorporation date
01/09/2009Share capital
400,000.00 PLNPrimary activity
Manufacture of perfumes and toilet preparations (20.42.Z - PKD 2007)Representatives
0Representatives rights
KAŻDY CZŁONEK ZARZĄDU SAMODZIELNIERepresentatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
1,323,595Net Profit (zł)
1,323,595Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2021 |
|---|
| 17,021,052 |
| 973,062 |
| 732,921 |
| 0.54 |
| 2.22 |
| 4.31 |
| 8,263,424 |
| 7,471,309 |
| 3,357,270 |
| 3,827,623 |
| 2022 |
|---|
| 22,377,725 |
| 1,545,646 |
| 1,134,035 |
| 0.37 |
| 1.91 |
| 5.07 |
| 9,497,459 |
| 9,029,618 |
| 1,178,201 |
| 3,384,065 |
| 2023 |
|---|
| 25,328,190 |
| 1,484,278 |
| 1,323,595 |
| 0.48 |
| 3.59 |
| 5.23 |
| 10,821,054 |
| 4,695,585 |
| 3,493,294 |
| 3,034,907 |
| 2023 |
|---|
| 25,328,190 |
| 1,484,278 |
| 1,323,595 |
| 0.48 |
| 3.59 |
| 5.23 |
| 10,821,054 |
| 4,695,585 |
| 3,493,294 |
| 3,034,907 |
Turnover (zł)
2023
Turnover (zł)
25,328,190 zł
13 % *
Profit before tax (zł)
1,484,278 zł
-4 % *
Net Profit (zł)
1,323,595 zł17 % *
Working capital requirement (%)
0.48 
29.73 % *
Liquidity ratio
3.59 87.96 % *
Net profitability (%)
5.23 %3.16 % *
Equity (zł)
10,821,054 zł14 % *
Current liabilities (zł)
4,695,585 zł-48 % *
Non current liabilities (zł)
3,493,294 zł196 % *
Non-current Assets (zł)
3,034,907 zł
-10 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
EQUALAN PHARMA EUROPE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents
Date | Description |
|---|---|
15/11/2024 | OD 01.01.2023 DO 31.12.2023 |
01/12/2023 | OD 01.01.2022 DO 31.12.2022 |
06/01/2023 | OD 01.01.2021 DO 31.12.2021 |
15/10/2021 | OD 01.01.2020 DO 31.12.2020 |
09/10/2020 | OD 01.01.2019 DO 31.12.2019 |